188 related articles for article (PubMed ID: 505486)
1. Circulating platelet aggregates in sickle cell disease patients with and without vaso-occlusion.
Mehta P; Mehta J
Stroke; 1979; 10(4):464-6. PubMed ID: 505486
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of platelet aggregation in sickle cell disease.
Mehta P; Mehta J
J Pediatr; 1980 Feb; 96(2):209-13. PubMed ID: 7351581
[TBL] [Abstract][Full Text] [Related]
3. Significance of platelet activation in sickle cell anaemia.
Ibanga IA
Niger J Med; 2006; 15(2):148-50. PubMed ID: 16805172
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
Hierso R; Lemonne N; Villaescusa R; Lalanne-Mistrih ML; Charlot K; Etienne-Julan M; Tressières B; Lamarre Y; Tarer V; Garnier Y; Hernandez AA; Ferracci S; Connes P; Romana M; Hardy-Dessources MD
Br J Haematol; 2017 Mar; 176(5):805-813. PubMed ID: 27984639
[TBL] [Abstract][Full Text] [Related]
5. Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease.
Amin MA; Amin AP; Kulkarni HR
Ann Hematol; 2004 Jun; 83(6):331-5. PubMed ID: 15052371
[TBL] [Abstract][Full Text] [Related]
6. Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis.
Papadimitriou CA; Travlou A; Kalos A; Douratsos D; Lali P
Acta Haematol; 1993; 89(4):180-3. PubMed ID: 8212998
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
[TBL] [Abstract][Full Text] [Related]
8. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hypoxemia among children with sickle cell anemia during steady state and crises: a cross-sectional study.
Chinawa JM; Ubesie AC; Chukwu BF; Ikefuna AN; Emodi IJ
Niger J Clin Pract; 2013; 16(1):91-5. PubMed ID: 23377479
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation during steady state sickle cell disease.
Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV
J Med; 1983; 14(1):17-36. PubMed ID: 6224876
[TBL] [Abstract][Full Text] [Related]
11. Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease.
Lamarre Y; Romana M; Waltz X; Lalanne-Mistrih ML; Tressières B; Divialle-Doumdo L; Hardy-Dessources MD; Vent-Schmidt J; Petras M; Broquere C; Maillard F; Tarer V; Etienne-Julan M; Connes P
Haematologica; 2012 Nov; 97(11):1641-7. PubMed ID: 22689686
[TBL] [Abstract][Full Text] [Related]
12. Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.
Bennewitz MF; Jimenez MA; Vats R; Tutuncuoglu E; Jonassaint J; Kato GJ; Gladwin MT; Sundd P
JCI Insight; 2017 Jan; 2(1):e89761. PubMed ID: 28097236
[TBL] [Abstract][Full Text] [Related]
13. Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis.
Al-Subaie AM; Fawaz NA; Mahdi N; Al-Absi IK; Al-Ola K; Ameen G; Almawi WY
Eur J Haematol; 2009 Dec; 83(6):579-85. PubMed ID: 19702628
[TBL] [Abstract][Full Text] [Related]
14. Home Management and Prevention of Vaso-Occlusive Crisis of Sickle Cell Disease Knowledge among Nursing Students.
Hamid HIA; Shanmugam AJ; Alnassry SMA; Abdelgader AAM; Bashir WAH; Ali MAA; Madhappan A
J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):157-163. PubMed ID: 36912810
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of platelet aggregation in the vaso-occlusive crisis of sickle-cell anemia.
Stuart MJ; Stockman JA; Oski FA
J Pediatr; 1974 Nov; 85(5):629-32. PubMed ID: 4423856
[No Abstract] [Full Text] [Related]
16. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.
Wagdy R; Suliman H; Bamashmose B; Aidaroos A; Haneef Z; Samonti A; Awn F
Eur J Pediatr; 2018 Dec; 177(12):1745-1752. PubMed ID: 30194527
[TBL] [Abstract][Full Text] [Related]
17. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
Olabode JO; Shokunbi WA
West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
[TBL] [Abstract][Full Text] [Related]
18. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
[TBL] [Abstract][Full Text] [Related]
19. Circulating cell-free DNA in sickle cell disease: is it a potentially useful biomarker?
Al-Humood S; Zueriq R; Al-Faris L; Marouf R; Al-Mulla F
Arch Pathol Lab Med; 2014 May; 138(5):678-83. PubMed ID: 24786126
[TBL] [Abstract][Full Text] [Related]
20. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.
Weiner DL; Hibberd PL; Betit P; Cooper AB; Botelho CA; Brugnara C
JAMA; 2003 Mar; 289(9):1136-42. PubMed ID: 12622584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
